Literature DB >> 18128091

Rift Valley fever; the neurotropic adaptation of the virus and the experimental use of this modified virus as a vaccine.

K C SMITHBURN.   

Abstract

Entities:  

Keywords:  RIFT VALLEY FEVER

Mesh：

Substances：

Year:  1949        PMID： 18128091      PMCID： PMC2073103     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN： 0007-1021


× No keyword cloud information.
  49 in total

1.  Notes on Rift Valley fever.

Authors:  G M FINDLAY; E M HOWARD
Journal:  Arch Gesamte Virusforsch       Date:  1951

2.  [Morphological principles for new opinions on the pathological picture of poliomyelitis].

Authors:  R GADEKE
Journal:  Virchows Arch Pathol Anat Physiol Klin Med       Date:  1952

3.  Protection of sheep against Rift Valley fever virus and sheep poxvirus with a recombinant capripoxvirus vaccine.

Authors:  Reuben K Soi; Fred R Rurangirwa; Travis C McGuire; Paul M Rwambo; James C DeMartini; Timothy B Crawford
Journal:  Clin Vaccine Immunol       Date:  2010-09-28

4.  Rift Valley fever virus structural and nonstructural proteins: recombinant protein expression and immunoreactivity against antisera from sheep.

Authors:  Bonto Faburay; William Wilson; D Scott McVey; Barbara S Drolet; Hana Weingartl; Daniel Madden; Alan Young; Wenjun Ma; Juergen A Richt
Journal:  Vector Borne Zoonotic Dis       Date:  2013-08-20       Impact factor: 2.133

5.  Safety and efficacy of four-segmented Rift Valley fever virus in young sheep, goats and cattle.

Authors:  Paul J Wichgers Schreur; Nadia Oreshkova; Lucien van Keulen; Jet Kant; Sandra van de Water; Pál Soós; Yves Dehon; Anna Kollár; Zoltán Pénzes; Jeroen Kortekaas
Journal:  NPJ Vaccines       Date:  2020-07-24       Impact factor: 7.344

6.  Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs.

Authors:  M Bouloy; C Janzen; P Vialat; H Khun; J Pavlovic; M Huerre; O Haller
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

Review 7.  Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate.

Authors:  Tetsuro Ikegami
Journal:  Expert Rev Vaccines       Date:  2017-05-02       Impact factor: 5.217

8.  Recombinant Rift Valley fever vaccines induce protective levels of antibody in baboons and resistance to lethal challenge in mice.

Authors:  James F Papin; Paulo H Verardi; Leslie A Jones; Francisco Monge-Navarro; Aaron C Brault; Michael R Holbrook; Melissa N Worthy; Alexander N Freiberg; Tilahun D Yilma
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-23       Impact factor: 11.205

Review 9.  Rift valley fever vaccines.

Authors:  Tetsuro Ikegami; Shinji Makino
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

10.  Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention.

Authors:  Michel Pepin; Michele Bouloy; Brian H Bird; Alan Kemp; Janusz Paweska
Journal:  Vet Res       Date:  2010 Nov-Dec       Impact factor: 3.683
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.